C-Semaglutide 5mg/mL injection recalled over sterility concerns

Recall date

April 13, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Pharmacy Plus, Inc. dba Vital Care Compounder recalls C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS…

Recall number

D-0538-2023

FDA classification

Class II

Brand / firm

Pharmacy Plus, Inc. dba Vital Care Compounder

Sold / distributed

MS only

Why it was recalled

Lack of assurance of sterility.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402